Protein-S at Dr. Essa Lab

Protein-S at Dr. Essa Lab

The Protein-S test is a highly specialized laboratory investigation designed to evaluate the levels and functional activity of Protein S in the blood. Protein S is a crucial, vitamin K-dependent plasma glycoprotein synthesized primarily by hepatocytes in the liver, as well as by endothelial cells and megakaryocytes. It plays a pivotal role in the body’s natural anticoagulation system. Specifically, Protein S acts as a non-enzymatic cofactor for Activated Protein C (APC). Together, the APC-Protein S complex selectively degrades and inactivates coagulation Factors Va and VIIIa, which are essential rate-limiting proteins in the blood clotting cascade. By inhibiting these factors, Protein S helps regulate and limit thrombin generation, preventing the pathological formation of blood clots within the vascular system. At Dr. Essa Lab, we utilize advanced automated coagulation analyzers to perform precise assays for both Protein S antigen and functional activity, helping clinicians diagnose inherited or acquired thrombophilia with the highest degree of clinical accuracy.

Understanding the diagnostic value of a Protein-S assay is vital for patients experiencing recurrent or unexplained thrombotic events. A deficiency in Protein S—whether inherited due to genetic mutations or acquired as a result of underlying medical conditions—significantly increases an individual’s risk of developing venous thromboembolism (VTE), which manifests most commonly as deep vein thrombosis (DVT) or pulmonary embolism (PE). By measuring the concentration of free Protein S, total Protein S, or its overall functional activity, hematologists and physicians at Dr. Essa Lab in Karachi can accurately assess a patient’s hypercoagulable state. This enables the formulation of targeted, evidence-based prophylactic or therapeutic anticoagulation strategies, ultimately reducing the risk of life-threatening thrombotic complications and improving long-term patient outcomes.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy of your Protein-S test results at Dr. Essa Lab, strict adherence to specific patient preparation guidelines is essential. Because various medications, physiological states, and acute illnesses can profoundly alter plasma Protein S levels, patients must follow these instructions carefully:

• Timing of the Test: The test should ideally not be performed during an active, acute thrombotic event or while the patient is undergoing active treatment for a clot, as the consumption of coagulation factors can lead to a falsely low result. It is highly recommended to wait at least 4 to 6 weeks after an acute thrombotic episode before undergoing testing.
• Anticoagulant Discontinuation: Oral anticoagulant therapies, particularly vitamin K antagonists such as Warfarin (Coumadin), must be discontinued for at least 2 weeks prior to blood collection, under the strict supervision of the prescribing physician, as these medications directly lower Protein S levels.
• Heparin and DOACs: Direct oral anticoagulants (DOACs) like Rivaroxaban or Apixaban, as well as Heparin or Low-Molecular-Weight Heparin (LMWH), should also be discontinued for at least 24 to 48 hours before the test, as they can interfere with functional clotting assays.
• Fasting Guidelines: While fasting is not strictly mandatory, a light fast of 4 hours is recommended to prevent lipemia, which can interfere with optical coagulation instruments.
• Medication Disclosure: Patients should inform the laboratory staff of any estrogen-containing medications, such as oral contraceptives or hormone replacement therapy, as these can physiologically lower Protein S levels.

During the Procedure

The collection of a blood sample for a Protein-S assay at Dr. Essa Lab is a quick, safe, and routine venipuncture procedure performed by our highly trained phlebotomists. The patient is comfortably seated, and the phlebotomist identifies a suitable vein, typically the median cubital vein in the antecubital fossa of the arm. The skin over the selected vein is thoroughly cleansed with an antiseptic solution to prevent contamination. A tourniquet is briefly applied above the venipuncture site to increase venous pressure and make the vein more accessible. Using a sterile, single-use needle, the phlebotomist draws blood into a light blue-top tube containing a precise concentration of buffered sodium citrate (3.2%). This specific anticoagulant is crucial because it binds calcium ions, temporarily halting the coagulation process and preserving the plasma proteins for laboratory analysis. It is critical that the tube is filled completely to the designated fill line to maintain the exact 9:1 blood-to-anticoagulant ratio; underfilled or overfilled tubes can lead to inaccurate clotting times and invalid results. Once the draw is complete, the needle is gently withdrawn, pressure is applied to the site with a sterile gauze pad, and a small bandage is applied. The collected sample is immediately inverted gently several times to mix the blood with the citrate, and it is promptly transported to our specialized hematology department for centrifugation and analysis.

When is a Protein-S Performed?

Evaluating Unexplained Deep Vein Thrombosis (DVT)

Physicians frequently order a Protein-S test when a patient presents with signs and symptoms of unexplained or unprovoked deep vein thrombosis (DVT), particularly if the patient is under the age of 50. DVT typically occurs in the deep veins of the lower extremities, presenting with symptoms such as unilateral leg swelling, persistent calf pain or tenderness, localized warmth, and erythema. When a clot occurs without an obvious provoking factor—such as major surgery, prolonged immobilization, or severe trauma—it strongly suggests an underlying hypercoagulable state or inherited thrombophilia. Performing a Protein-S assay helps clinicians determine if a hereditary or acquired deficiency in this natural anticoagulant is the primary driver behind the thrombotic event, which directly influences the duration and intensity of the patient’s subsequent anticoagulation therapy.

Investigating Pulmonary Embolism (PE) Episodes

A pulmonary embolism (PE) is a life-threatening medical emergency that occurs when a blood clot detaches from a deep vein and travels to the lungs, blocking one or more pulmonary arteries. Symptoms of PE include sudden-onset dyspnea (shortness of breath), sharp or pleuritic chest pain that worsens with deep breathing, tachypnea, tachycardia, and hemoptysis (coughing up blood). In patients who survive an acute PE, identifying the root cause is paramount to preventing recurrent, potentially fatal episodes. A Protein-S test is a key component of the comprehensive thrombophilia workup performed at Dr. Essa Lab. Identifying a Protein S deficiency in these patients provides critical prognostic information, often indicating the need for long-term or indefinite oral anticoagulation to safeguard against future thromboembolic events.

Assessing Recurrent Pregnancy Loss and Obstetric Complications

Protein S deficiency is clinically recognized as a significant risk factor for adverse pregnancy outcomes, including recurrent first- and second-trimester miscarriages, unexplained late-term fetal demise, severe preeclampsia, placental abruption, and intrauterine growth restriction (IUGR). During pregnancy, the maternal body naturally enters a hypercoagulable state to prevent excessive bleeding during delivery; however, an underlying Protein S deficiency can exacerbate this state, leading to microvascular thrombosis within the placental circulation. This restricts blood flow and nutrient delivery to the developing fetus. Obstetricians and maternal-fetal medicine specialists frequently recommend a Protein-S test for women with a history of recurrent pregnancy loss to identify treatable thrombophilias, allowing for timely intervention with low-dose aspirin or low-molecular-weight heparin (LMWH) in subsequent pregnancies.

Screening for Inherited Thrombophilia and Family History

A strong family history of early-onset venous thromboembolism, recurrent clotting disorders, or documented hereditary thrombophilia is a primary indication for Protein-S screening. Inherited Protein S deficiency is an autosomal dominant disorder, meaning offspring have a 50% chance of inheriting the genetic mutation if one parent is affected. Asymptomatic individuals with a confirmed family history of the deficiency can undergo testing at Dr. Essa Lab to determine their personal risk profile. Knowing one’s thrombophilic status is incredibly valuable, as it allows individuals and their healthcare providers to implement proactive prophylactic measures during high-risk scenarios, such as major surgical procedures, prolonged air travel, periods of extended immobilization, or pregnancy.

Monitoring Acquired Protein S Deficiency States

While hereditary deficiency is a major concern, acquired Protein S deficiency is far more common and occurs secondary to various clinical conditions. Because Protein S is synthesized in the liver and requires vitamin K for its functional activation, patients with chronic liver disease, cirrhosis, or severe vitamin K deficiency will exhibit significantly reduced Protein S levels. Additionally, inflammatory states can lower free Protein S levels because Protein S binds to C4b-binding protein (C4b-BP), an acute-phase reactant that increases during inflammation, thereby reducing the active, free fraction of Protein S. Clinicians utilize the Protein-S test at Dr. Essa Lab to monitor these acquired states, assess the overall thrombotic risk in patients with nephrotic syndrome (where Protein S is lost in the urine), and evaluate patients with severe infections or disseminated intravascular coagulation (DIC).

What Does a Protein-S Detect?

The Protein-S test performed at Dr. Essa Lab is highly sensitive and capable of detecting a wide array of physiological and pathological states related to blood coagulation. Specifically, this comprehensive assay can detect, differentiate, or assist in evaluating the following clinical findings:

• Inherited Type I Protein S Deficiency: Characterized by a concordant reduction in total Protein S antigen, free Protein S antigen, and functional Protein S activity.
• Inherited Type II Protein S Deficiency: Identified when total and free Protein S antigen levels are normal, but the functional activity of the protein is significantly reduced.
• Inherited Type III Protein S Deficiency: Marked by normal total Protein S antigen levels but significantly decreased free Protein S antigen and functional activity.
• Acquired Vitamin K Deficiency: Since Protein S requires vitamin K for gamma-carboxylation, deficiency in this vitamin leads to dysfunctional, inactive Protein S.
• Warfarin-Induced Coagulation Alterations: Detects the therapeutic or supratherapeutic suppression of vitamin K-dependent proteins during oral anticoagulant therapy.
• Severe Hepatic Dysfunction: Reflects impaired synthetic capacity of the liver due to cirrhosis, hepatitis, or acute liver failure.
• Active Disseminated Intravascular Coagulation (DIC): Detects severe consumption of Protein S due to widespread microvascular clot formation.
• Pregnancy-Induced Physiological Changes: Identifies the normal, temporary reduction in free Protein S levels that occurs during gestation.
• Oral Contraceptive-Induced Reductions: Detects the mild to moderate decrease in Protein S activity caused by estrogen-containing birth control pills.
• Hormone Replacement Therapy (HRT) Effects: Evaluates the impact of exogenous estrogen on the natural anticoagulant pathway in postmenopausal women.
• Nephrotic Syndrome-Associated Loss: Detects the depletion of plasma Protein S due to its excretion in the urine alongside other low-molecular-weight proteins.
• Acute Phase Inflammatory Responses: Identifies a reduction in free Protein S caused by elevated C4b-binding protein levels during acute infections or chronic inflammatory diseases.
• Neonatal Purpura Fulminans Risk: Assists in diagnosing rare, life-threatening homozygous or compound heterozygous Protein S deficiencies in newborns.
• Systemic Lupus Erythematosus (SLE) Complications: Detects acquired deficiencies associated with autoimmune-mediated clearance or anti-Protein S antibodies.
• Active Consumption During Acute VTE: Reveals transiently depleted Protein S levels immediately following an acute deep vein thrombosis or pulmonary embolism.
• L-Asparaginase Chemotherapy Side Effects: Monitors the drug-induced suppression of hepatic protein synthesis in leukemia patients.
• Sickle Cell Disease Hypercoagulability: Evaluates the chronic depletion of natural anticoagulants in patients with sickle cell crises.
• Chronic Renal Failure Alterations: Assesses the complex balance of procoagulant and anticoagulant factors in patients with advanced kidney disease.
• Post-Operative Transient Hypercoagulability: Identifies temporary drops in anticoagulant proteins following major surgical trauma.
• Normal Coagulation Status: Confirms adequate levels and activity of Protein S, effectively ruling out primary Protein S deficiency as a cause for clotting.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that timely diagnostic results are critical for effective clinical decision-making and patient peace of mind. For specialized hematology investigations such as the Protein-S test, which require precise automated coagulation profiling and meticulous quality control, our standard turnaround time is typically within 24 to 48 hours. Our laboratory utilizes state-of-the-art, fully automated coagulation analyzers that minimize human error and expedite the testing process. Once the analysis is complete and verified by our consultant pathologists, patients receive an immediate SMS notification. Reports can be accessed instantly online through the secure Dr. Essa Lab web portal or our dedicated mobile application. For added convenience, patients can also receive their high-resolution PDF reports directly via WhatsApp, or collect a physical copy from any of our numerous collection centers located across Karachi and other major cities in Pakistan.

Protein-S Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Free Protein S Antigen	Typically 60% to 140% (varies slightly by age and sex)	Decreased in Type I and Type III inherited deficiencies, pregnancy, OCP use, and liver disease.
Total Protein S Antigen	Typically 60% to 140% (reflects both free and bound forms)	Decreased in Type I inherited deficiency and severe liver disease; normal in Type III.
Functional Protein S Activity	Typically 60% to 140% (measures cofactor activity for APC)	Decreased in all types (I, II, and III) of inherited deficiencies, vitamin K deficiency, and warfarin therapy.
Type I Deficiency Profile	Not applicable (Normal state)	Concordant decrease in Free Antigen, Total Antigen, and Functional Activity.
Type II Deficiency Profile	Not applicable (Normal state)	Normal Free and Total Antigen levels, but significantly decreased Functional Activity.
Type III Deficiency Profile	Not applicable (Normal state)	Normal Total Antigen, but decreased Free Antigen and decreased Functional Activity.
Acquired Deficiency (Liver/Warfarin)	Not applicable (Normal state)	Markedly decreased functional activity and antigen levels due to impaired synthesis or gamma-carboxylation.
C4b-Binding Protein (C4b-BP) Influence	Normal balance of free (40%) and bound (60%) Protein S	Elevated C4b-BP during inflammation, shifting more Protein S to the bound, inactive state, lowering free Protein S.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Protein-S?

• Decades of Diagnostic Excellence: Serving Pakistan since 1987, Dr. Essa Lab is a pioneer in high-quality medical diagnostics and pathology services.
• Advanced Coagulation Technology: We utilize state-of-the-art, fully automated coagulation analyzers to ensure maximum precision and reproducibility of Protein-S assays.
• Expert Pathologist Supervision: Every specialized hematology report is reviewed and verified by highly qualified consultant pathologists and hematologists.
• Rigorous Quality Control: Our laboratories strictly adhere to international quality control protocols and participate in external quality assurance programs.
• Convenient Home Sample Collection: Patients can schedule professional, sterile blood sample collection from the comfort of their homes across Karachi.
• Rapid Turnaround Time: Efficient processing ensures that your specialized Protein-S results are ready and verified within 24 to 48 hours.
• Seamless Digital Report Access: Easily download and share your reports via our secure online portal, mobile app, or directly through WhatsApp.
• Affordable and Transparent Pricing: We offer highly competitive rates for specialized thrombophilia panels, making essential healthcare accessible to all.